Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

Davies, P ; Arbyn, M ; Dillner, Joakim LU ; Kitchener, HC ; Meijer, CJLM ; Ronco, G and Hakama, M (2006) In International Journal of Cancer 118(4). p.791-796
Abstract
Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost-effectiveness of these new technologies must be established in properly designed trials before they can be implemented within national public health programs. Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test. (c) 2005 Wiley-Liss, Inc.
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
review, trial, randomized controlled, screening, human papillomavirus, cervical cancer
in
International Journal of Cancer
volume
118
issue
4
pages
791 - 796
publisher
John Wiley and Sons
external identifiers
  • pmid:16287075
  • wos:000234944000001
  • scopus:31544466266
  • pmid:16287075
ISSN
0020-7136
DOI
10.1002/ijc.21611
language
English
LU publication?
yes
id
998d019e-7611-4e59-ad7f-8c09169b0f3a (old id 419449)
date added to LUP
2016-04-01 12:09:33
date last changed
2021-02-17 03:11:28
@article{998d019e-7611-4e59-ad7f-8c09169b0f3a,
  abstract     = {Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost-effectiveness of these new technologies must be established in properly designed trials before they can be implemented within national public health programs. Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test. (c) 2005 Wiley-Liss, Inc.},
  author       = {Davies, P and Arbyn, M and Dillner, Joakim and Kitchener, HC and Meijer, CJLM and Ronco, G and Hakama, M},
  issn         = {0020-7136},
  language     = {eng},
  number       = {4},
  pages        = {791--796},
  publisher    = {John Wiley and Sons},
  series       = {International Journal of Cancer},
  title        = {A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening},
  url          = {http://dx.doi.org/10.1002/ijc.21611},
  doi          = {10.1002/ijc.21611},
  volume       = {118},
  year         = {2006},
}